The Rise of China’s Longevity Movement: A Quest to Defy Aging

China’s national project to crush aging encompasses longevity labs, “immortality islands,” and grapeseed pills, as well as exorbitant claims based on sometimes questionable science.

(Attendees at a conference in Shanghai try out a cryogenic chamber in which temperatures plummeted to approximately -200 degrees Fahrenheit, meant to slow aging | New York Times)

A surge in the Chinese public’s interest in longevity science has led to substantial investments from the state and private companies in aging research.

Aging &amp; Longevity

Eric Verdin, M.D., and Peter Attia, M.D., discuss the controversy surrounding NAD+ (nicotinamide adenine dinucleotide), the best method for replenishing NAD+, and more.


Latest Human Trial from the Buck Institute Shows Plasma Exchange Lowers Biological Age

A new human study shows that a procedure involving the replacement of blood plasma with a fresh solution (therapeutic plasma exchange) lowers a measure of how quickly the body is aging (biological age).

(The Buck Institute for Research on Aging | Facebook)

In a first-of-its-kind human trial, participants who underwent therapeutic plasma exchange exhibited significantly lowered biological age.

NAD+ Supercharges Immune System Recovery in Older Mice

Researchers from the University of California, Berkeley, found that young mice need NAD+ breakdown, while old mice need NAD+ boosting.

Immunity

Exploring Longevity Drugs in an Era of Slumping Investments and Rising Doubt

Venture capitalists have put the brakes on investments in longevity-related interventions over the past few years, yet experts predict new drug approvals will spur a funding surge.

Despite slumping investments in longevity-related biotech companies over the last few years, experts predict a funding surge as new therapies get closer to approval.

Search Result: Buck Institute for Research on Aging

The Rise of China’s Longevity Movement: A Quest to Defy Aging

Top Aging Expert & Peter Attia Discuss NAD+ Precursors: Taking NMN and NR Together

Latest Human Trial from the Buck Institute Shows Plasma Exchange Lowers Biological Age

NAD+ Supercharges Immune System Recovery In Older Mice, Hurts Blood Stem Cells of Young Mice

Exploring Longevity Drugs in an Era of Slumping Investments and Rising Doubt